 Byspecific antibody engineering combines binding specificities toward two distinct epitopes into a single molecule to enhance immunotherapeutic properties of monoclonal antibodies and recent advances in the development of biospecific antibodies for viral immunotherapy show promising results. This article was authored by Elizabeth K. Nyokitura, Alexandra Weisaw and Jonathan R. Lai.